Posts With Tag BioNTech SE

Explore BioNTech SE's Form 6-K filing detailing strategic priorities and updates from the 2025 J.P. Morgan Healthcare Conference, enhancing transparency for investors.

Explore BioNTech SE's Form 6-K report detailing a $791.5M settlement with the NIH over COVID-19 vaccine royalties and new licensing terms effective January 2024.